Skip to content

Dr. Michelessi Manuele

Ophthalmologist, Researcher
Michelessi Manuele
Research line: Research Line of Glaucoma and anterior segment with ocular annexes
Research unit: RU Glaucoma
Simple Operating Unit: Simple Operating Unit Glaucoma and Hospital-Territory Integration 
Specialization: Ophthalmology
Professional register: Register of Physicians and Surgeons of Rome (Medical Board of the Province of Rome), No. 56930 dated 17 February 2009

Practices at IRCCS Fondazione G.B. Bietti at the premises of Via Livenza 3 and Via di Santo Stefano Rotondo 6, Presidio Ospedaliero Britannico, Rome.

Scientific Publications: PubMed

LinkedIn Profile:: Michele Michelessi

 

  • 2007: Degree in Medicine and Surgery with highest honors (110/110 cum laude), University of Rome “Tor Vergata.” Thesis: “Influence of optic disc size on the diagnostic accuracy of HRT 3”, supervised by Prof. Marco Centofanti.
  • 2008: Second-Level Master’s Degree in Statistics Applied to Clinical Questions, University of Modena and Reggio Emilia.
  • 2014: Specialization in Ophthalmology with highest honors (50/50 cum laude), University of Rome “Tor Vergata.” Thesis: “Optic nerve head and fiber layer imaging for diagnosing glaucoma: a systematic review”, supervised by Prof. Gianluca Manni.
  • 2013–2014: 15-month fellowship as Researcher at the Bloomberg School of Public Health, Johns Hopkins Hospital, Baltimore (USA), under the supervision of Prof. Kay Dickersin, focusing on systematic reviews and methodologies for conducting clinical trials.
  • Since 2015: Member of the International Glaucoma Panel V and Mentoring Program, a professional training and international networking initiative for young ophthalmologists and researchers specializing in glaucoma, led by Prof. Ted Garway-Heath (Moorfields Eye Hospital, London, UK).
  • January 2015 – present: Ophthalmologist, Researcher at IRCCS Fondazione G.B. Bietti, Rome, Italy.

  • NGP Co-Chair, Guideline Committee on Glaucoma – European Glaucoma Society (EGS)

  • Co-Chair, Glaucoma Outcomes Committee – European Glaucoma Society (EGS)

  • NGP Member, Scientific Committee – European Glaucoma Society (EGS)

  • Member, Italian Society of Ophthalmology (SOI)

  • Member, Italian Association for the Study of Glaucoma (AISG)

  • Member, Association for Research in Vision and Ophthalmology (ARVO)

  • Member, Cochrane Eye and Vision Group, within the Cochrane Collaboration

  • Member, European Glaucoma Society – Next Generation Partnership (EGS-NGP)

  • A prospective, double-masked, randomized, multicenter, active- controlled, parallel-group, 6-month study assessing the safety and ocular hypotensive efficacy of PG324 Ophthalmic Solution compared to GANFORT® (bimatoprost 0.03%/timolol 0.5%) Ophthalmic Solution in subjects with elevated intraocular pressure (MERCURY 3)
  • Treating investigator nel trial “Studio di fase 3b teso a valutare la durata dell’effetto di bimatoprost SR in partecipanti con glaucoma ad angolo aperto o ipertensione oculare”
  • A phase iii, multinational, multicenter, investigator-masked, randomised, active-controlled trial, comparing the efficacy and safety of de-130a with xalatan®in patients with open-angle glaucoma or ocular hypertension over a 3-monthperiod, followed by a 12-month follow-up with open-label de-130a treatment.

Editorial activity as reviewer for international journals with impact factor:

  • Ophthalmology

  • American Journal of Ophthalmology

  • PLOS ONE

  • Graefe’s Archive for Clinical and Experimental Ophthalmology

  • Indian Journal of Ophthalmology

  • Eye

  • Since 2016: Editor for the Cochrane Collaboration with the Cochrane Eye and Vision Group

Skip to content